"..Medium term" spoils it a bit, but am sure they're aware it's just the one huge seller knocking the share price to the floor.
Good to see them making progress - is only a waiting game. |
What could the options be ?
Melanie Gee, Chair of Syncona Limited, commented: "The Board remains frustrated by the share price performance and widening discount to NAV. The fundamentals of the portfolio are robust given the rebalancing to later stage companies and the number of recent financings supported by third party investors that externally validate the valuation of these portfolio companies. The Board is confident that the portfolio is well placed to deliver strong risk adjusted returns over time. Nonetheless given challenging broader market conditions and headwinds in the investment companies' sector, the Board together with SIML will continue to review options to maximise value for shareholders over the medium term." |
Large volume again today. We must be near the end of this seller and i suppose the positive is someone else must be buying. The relentless fall is rather depressing. |
RICA, CGT, or PNL all seem good at the right moments, but they've barely beaten cash for a long while now. Makes me think I can do better :) But as you say, sitting on hands is sometimes better, and timing is both impossible, and everything.
SYNC will come good - am almost sure of it - but when, and how low first, who knows. |
@specto thanks - I hold all of those as recent-ish buys but they haven't quite made it into the top 5 yet. Can't quite bring myself to aggressively sell down some of the other growthier alternatives like PE (every time I have trimmed them and bought renewables, sitting on my hands would have been more beneficial! But that also goes for topping up SYNC... )
CGT seems to be limiting IT exposure to keep liquidity high (I guess partly because of the buyback) so seems to be caught a bit between two stools.
I have bought some RICA, just in case things go pear shaped. |
Today’s news seems of little consequence. In June 24 the value of the holding was £7.1m and it seems they will get more in return. |
Agreed re Achilles, looked bad but actually good :)
@CousinIT - I'd been pretty defensively positioned, had ERNS and CGT in top 5 holdings, as well as some CSH2, gold, & Gilts elsewhere. Had a Gilt maturity, sold out completely of CSH2, almost sold out of ERNS & CGT. All into risk assets.
Top 5 now SEIT, ASLI, FGEN, TRIG, FSFL. Only ASLI non-risk.
I might be wrong - very wrong - and this could be the end of renewables. If not, there's a lot in the prices as you say, & paid to wait.
Saying that, obviously down on all atm.
(SYNC, fwiw, now my 7th largest holding. Can absolutely go lower, by tens of pence, but IMO artificially down here due to fund manager merger/major seller).
Edit - was a time I had 4 REITs in Top 5, and long before that 4 PE - but logic says eventually it'll go badly wrong. |
The Achilles liquidation should at least add to the buyback runway.
@specto, you seem to be topping up a lot of names, especially in renewables. May I ask what you're selling to fund that? Or just reducing cash? Lots of value seems to be out there but doesn't look like it will be a smooth ride either! |
Market completely ignored todays news, will add too if price drops into eighties |
Trouble is, the size of the stake is so large, even a few million probably doesn't signal the end of it.
But who cares - I'm in SYNC for the mid term, it's cheap IMO, & added again today.
Good luck holders. |
Hopefully the selling is nearly over. Some big trades have gone through today. |
Sigmund i was hoping you were right but recent weakness looks like we will be testing new lows. The share buy back is having no effect. |
bought at 93.5p
biotech is bombed out right now
sync on discount of 48% (!)
so it is a leveraged play on a bombed out sector.
autolus CRT drug looks the best in the business, for a terrible condition that a lot of young people get, so there is motivation to get them better and to pay for it.
i like some of the other investee research but lot of it is just that and a phase 3 trial can always crash and burn.
so where next for price? the chart is interesting. it has been in a descending channel for some time, with an acceleration towards the bottom. however it is at a crucial point, with a likely marked move up or down soon.
this is entirely a guess, but i am saying to the upside!
free stock charts from uk.advfn.com |
Definitely doesn't help, but I'm for the known stake sale - and gritting teeth to buy more. |
Same here but I bought in at 120 and then again at 100.
Could be a wall of worry about what is going to happen after Donald Trump is inaugurated on 20th January? |
For an investment trust that doesnt seem to have a huge following there are so many shares being traded which leads me to believe that a fund must be offloading as why all this volume. I thought buying in at just over £1 was a reasonable entry point with limited downside but the fall is relentless even with the buy back. Hopefully this will reverse soon.
Reading through the latest monthly update all the recent news has been positive. |
For what its worth, brought back the few sold into EOY rise
Hoping its a seller and the market demanding bigger discount rate to match the long curve rising |
There is obviously a big seller out there because even with the buy back the shares keep falling. Yesterday they bought back 500k, more than usual. I havent seen any negative news, only positives ! |
Remain convinced there's value in SYNC, but from what level..
Still a holder. |
Craig Baker of Alliance Witan shows a slide of ITs transferred from Witan. He says they will hold them until value realised. It is at about 23mins in on the presentation. |
Beacon last week and now iOnctura
iOnctura reaches new clinical milestones in uveal melanoma |
Good news keeps flowing (see recent announcements) . These will hopefully rerate soon. There must be a large seller around as the current buy back is doing nothing to the share price. |
Hoping this can recover during 25'.......... |
Added a few here too. Didn't take 10p profit on the last bounce but despite the chance of upset (investee co's failing trials etc), the downside seems limited to me. |
Just added a small amount to my holding. |
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
